Author:
Pupillo Elisabetta,Bianchi Elisa,Bonetto Valentina,Pasetto Laura,Bendotti Caterina,Paganoni Sabrina,Mandrioli Jessica,Mazzini Letizia
Funder
Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
Reference13 articles.
1. Association between decline in slow vital capacity and respiratory insufficiency, use of assisted ventilation, tracheostomy, or death in patients with amyotrophic lateral sclerosis;Andrews;JAMA Neurol.,2018
2. Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial;Beghi;Eur. J. Neurol.,2023
3. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population;Czaplinski;J. Neurol. Neurosurg. Psychiatry,2006
4. Longitudinal biomarkers in amyotrophic lateral sclerosis;Huang;Ann. Clin. Transl. Neurol.,2020
5. Neuromuscular transmission and muscle fatigue changes by nanostructured oxygen;Ivannikov;Muscle Nerve,2017